4.6 Article

Semi-Supervised Learning Algorithm for Identifying High-Priority Drug-Drug Interactions Through Adverse Event Reports

Journal

Publisher

IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
DOI: 10.1109/JBHI.2019.2932740

Keywords

Drugs; Machine learning algorithms; Machine learning; Semisupervised learning; Prediction algorithms; Feature extraction; Support vector machines; Semi-supervised learning; stacked autoencoder; classification; drug-drug interactions; clinical decision support; adverse event reports

Funding

  1. Allen E. Pearce and Allen M. Pearce Professorship

Ask authors/readers for more resources

Identifying drug-drug interactions (DDIs) is a critical enabler for reducing adverse drug events and improving patient safety. Generating proper DDI alerts during prescribing workflow has the potential to prevent DDI-related adverse events. However, the implementation of DDI alerting system remains a challenge as users are experiencing alert overload which causes alert fatigue. One strategy to optimize the current system is to establish a list of high-priority DDIs for alerting purposes, though it is a resource-intensive task. In this study, we propose a machine learning framework to extract useful features from the FDA adverse event reports and then identify potential high-priority DDIs using an autoencoder-based semi-supervised learning algorithm. The experimental results demonstrate the effectiveness of using adverse event feature representations in differentiating high- and low-priority DDIs. Additionally, the proposed algorithm utilizes stacked autoencoders and weighted support vector machine for boosting classification performance, which outperforms other competing methods in terms of F-measure and AUC score. This framework integrates multiple information sources, leverages domain knowledge and clinical evidence, and provides a practical approach for pre-screening high-priority DDI candidates for medication alerts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available